Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cardiff Oncology, Inc. - Common Stock (NQ:CRDF)

2.095 +0.095 (+4.75%)
Streaming Delayed Price Updated: 2:07 PM EDT, Sep 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cardiff Oncology, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
A Glimpse Into The Expert Outlook On Cardiff Oncology Through 4 Analysts
 
Via Benzinga
AMD To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Wednesday
 
Via Benzinga
Cardiff Oncology (CRDF) Q2 Loss Down 19%
Via The Motley Fool
Why Is Cardiff Oncology Stock Trading Lower After Colorectal Cancer Data?
Onvansertib combined with standard care showed up to 49% confirmed ORR in RAS-mutated colorectal cancer, with early signs of PFS benefit. 
Via Benzinga
Which stocks are experiencing notable movement on Wednesday?
Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
Earnings Scheduled For February 27, 2025
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
Traders are paying attention to the gapping stocks in Wednesday's session.
In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down. 
Via Chartmill
These stocks are moving in today's pre-market session
As we await the opening of the US market on Wednesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Avis Budget Group Posts Downbeat Earnings, Joins SoFi Technologies, Seagate And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
 
Via Benzinga
Cardiff Oncology Shares Slide Over 26% In Premarket Trading After Mixed Q2
Cardiff Oncology Inc. (NASDAQ: CRDF) plummeted 22.96% in its stock value on Tuesday, following a disappointing second quarter earnings report. 
Via Benzinga
Why LendingClub Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
What's going on in today's after hours session
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
This MakeMyTrip Analyst Turns Bullish; Here Are Top 3 Upgrades For Tuesday
 
Via Benzinga
This Amylyx Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Top movers in Tuesday's after hours session
Discover the top movers in Tuesday's after-hours session and stay informed about the post-market dynamics. 
Via Chartmill
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
US Small Business Optimism Hits 3-Year High As Election Results 'Signal A Major Shift'
Small businesses are entering the holiday season with newfound confidence and momentum, thanks to post-election policies and reduced inflation. 
Via Benzinga
What's Going On With Cardiff Oncology Stock On Tuesday?
Cardiff Oncology's CRDF-004 trial shows promising onvansertib results in RAS-mutated mCRC patients, with higher tumor response rates and a strong safety profile. 
Via Benzinga
CRDF Stock Earnings: Cardiff Oncology Misses EPS, Beats Revenue for Q2 2024
CRDF stock results show that Cardiff Oncology missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
The $5 Phenoms: 3 Cheap Stocks That Could Skyrocket by 2028
Finding good investing possibilities in the constantly changing stock market might be likened to unearthing buried jewels. 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
CRDF Stock Earnings: Cardiff Oncology Beats EPS, Beats Revenue for Q1 2024
CRDF stock results show that Cardiff Oncology beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024?
These seven companies were the top 2020 stocks. After their glory years have faded, they are looking to turn their fortunes around. 
Via InvestorPlace
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.